Cambridge scientists have stated that advances in genetics are about to revolutionize breast cancer treatment for women, therefore creating more personalised care for each individual.
A new, fast-acting flu drug that can control flu symptoms in a single dose has been granted priority review by the US Food and Drug Administration.
Researchers from The Scripps Research Institute in San Diego, California have discovered that the activation of the brain receptor, GPR139, can relieve alcohol withdrawal symptoms and block alcohol addiction.
An oral delivery method that could completely change the way diabetics monitor their blood sugar levels has been generated by researchers from Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS).
Scientists are currently investigating Xofluza, a new influenza drug created by Japanese pharmaceutical company Shionogi that was approved for clinical use in Japan in February 2018.
Researchers from the University of California’s Department of Medicine conducted a randomized clinical trial to examine the safety and side effects of three commonly used smoking cessation drugs: bupropion, varenicline and nicotine-replacement therapy.
A genetically modified poliovirus could possibly be used as a treatment to save brain cancer patients.
The study was conducted by Duke University researchers and The National Cancer Institute produced the modified virus.
The University of New South Wales (UNSW) scientists will soon be conducting a world-first brain imaging study of people who have an unusual mental condition known as congenital aphantasia.
According to new research, numerous Australian medical professionals lack extreme confidence in giving advice to pregnant women on how to prevent cytomegalovirus (CMV), a common virus that can cause disabilities in babies.